DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

This Upcoming Event Could Affect Sarepta Therapeutics Investors

Emergent BioSolutions Inks Deals for Its Ebola Vaccine - Analyst Blog

Sarepta Therapeutics Inc (SRPT) CEO Christopher Garabedian on Barclays Healthcare Conference - Trans

Sarepta Therapeutics Inc (SRPT) CEO Christopher Garabedian on Barclays Healthcare Conference - Transcript

3 Easy Ways to Fail When Investing in Biotech Stocks

Our experts help you avoid these common mistakes.

Insider Trading Alert - SRPT, SNA And TUP Traded By Insiders

Sarepta Therapeutics Inc.'s Price Target Was Slashed By 27% -- Time to Panic?

It's been a rough 12 months for Sarepta Therapeutics, and it got even rougher on Monday following a substantial price target cut from a Wall Street firm. Find out whether this price cut is justified and what investors should consider doing next.

Did Researchers Just Discover a Functional Cure for Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy has no cure, and it often kills its victims by their mid-20s. However, a new international study lends hope that a functional cure to this disease could be in the offing.

Sarepta Therapeutics (SRPT) Q4 2014 Results - Earnings Call Webcast

Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog

Will BioMarin (BMRN) Beat Estimates this Earnings Season? - Analyst Blog

See More Articles...